BRISBANE, Calif., Jan. 7 /PRNewswire/ -- InterMune, Inc. (Nasdaq: ITMN)
today announced that W. Scott Harkonen, MD, the Company's President and Chief
Executive Officer, will present at the 20th Annual JPMorgan H&Q Healthcare
Conference in San Francisco, California on Thursday, January 10, 2002 at
9:00 a.m. (PST).
The audio webcast and presentation slides may be accessed by visiting
InterMune's website at http://www.intermune.com and clicking on the "Investor
Relations" icon.
InterMune is a commercial-stage biotechnology company dedicated to
developing innovative products for the treatment of serious pulmonary and
infectious diseases and cancer. InterMune has three marketed products, growing
product revenues and advanced-stage clinical programs addressing a range of
diseases with attractive commercial markets. For additional information about
InterMune, please visit http://www.intermune.com.
SOURCE InterMune, Inc.
 back to top
Related links:
http://www.intermune.com
CONTACT:
investors, Lisa Hansen, +1-415-466-2242, or
lhansen@intermune.com, or press, Kim Kraemer, +1-415-388-7994,
kraemer@dnai.com, both of InterMune, Inc.
|
